Skip to content

    Announcements

    Attention All WebMD Community Members:

    These message boards are closed to posting. Please head on over to our new WebMD Message Boards to check out and participate in the great conversations taking place: https://messageboards.webmd.com/

    Your new WebMD Message Boards are now open!

    Making the move is as easy as 1-2-3.

    1. Head over to this page: https://messageboards.webmd.com/living-healthy/f/womens-health/

    2. Choose the tag from the drop-down menu that clicks most with you (and add it to any posts you create so others can easily find and sort through posts)

    3. Start posting

    Have questions? Email us anytime at [email protected]

    New HRT Guidelines released
    avatar
    maxprovust posted:
    With a sigh of relief, British doctors received new guidelines regarding HRT from the British Menopause Society and Women's Health Concern in May 2013. The guidelines - "The 2013 British Menopause Society & Women's Health Concern recommendations on hormone replacement therapy" [br>

    The new guidelines are the result of extensive consultations and meetings among "Panel of Experts".


    The new guidelines include the following key points:
    • An individual decision - each patient must receive proper and comprehensive information from her doctor so that she can make a fully-informed choice. Whether or not to use HRT is an individual decision.

    • HRT dosage - should be calculated on an individual basis, as should overall regimen and duration.

    • Annual evaluation - every woman on hormone replacement therapy must have her treatment evaluated once a year for pros and cons.

    • No arbitrary limits on duration - the duration of HRT usage should not be restricted by arbitrary limits. "If symptoms persist, the benefits of hormone therapy usually outweigh the risks."

    • HRT more favorable for younger patients - when deciding on HRT usage, the patient as well as the doctor must remember that there is a more favorable benefit/risk profile for patients who start therapy before they are 60 years old.

    • Premature ovarian insufficiency - patients should be on HRT at least until the average age of the menopause.

    • Older patients - patients over 60 who are prescribed HRT should initially be on lower doses and ideally with a transdermal route of administration.

    • R&D must focus on risks and benefits - as people continue having longer lifespans, research and development needs to concentrate on maximizing benefits and minimizing risks and side effects. "This will optimize quality of life and facilitate the primary prevention of long-term conditions which create a personal, social and economic burden."


    Featuring Experts

    Mary Jane Minkin, MD, is a nationally recognized obstetrician gynecologist, with a special interest in menopause. Dr. Minkin is clinical professor of ...More

    Helpful Tips

    Fact or fiction? Estrogen therapy is an option for all menopausal womenExpert
    Fiction: Only women who no longer have a uterus should consider using esdtrogen-alone therapy (ET). For women with a uterus, the option ... More
    Was this Helpful?
    33 of 47 found this helpful

    Related Drug Reviews

    • Drug Name User Reviews

    Report Problems With Your Medications to the FDA

    FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    For more information, visit the North American Menopause Society website